{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:46:10Z","timestamp":1791387970797,"version":"4.3.3"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1001\/jama.2020.22240","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T16:00:28Z","timestamp":1604937628000},"page":"2165","source":"Crossref","is-referenced-by-count":354,"title":["Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19"],"prefix":"10.1001","volume":"324","author":[{"given":"Wesley H.","family":"Self","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Semler","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Leither","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, Utah"},{"name":"University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Casey","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy G.","family":"Brower","sequence":"additional","affiliation":[{"name":"Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Ronald Reagan\u2013UCLA Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Eppensteiner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Filbin","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Clark","family":"Files","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, Allergy and Immunologic Disease, Department of Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, Allergy and Immunologic Disease, Department of Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adit A.","family":"Ginde","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Gong","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Population Health, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Frank E.","family":"Harrell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Hayden","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hough","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University School of Medicine, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University School of Medicine, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Lindsell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Matthay","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Departments of Medicine and Anesthesia, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Moss","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline K.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Rice","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce R. H.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Schoenfeld","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Steingrub","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Ulysse","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Weissman","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Yealy","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Taylor","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, Utah"},{"name":"University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Heart, Lung, and Blood Institute PETAL Clinical Trials Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"joi200119r3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105982","article-title":"Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.","volume":"55","author":"Zhao","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"joi200119r4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"18","key":"joi200119r5","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review.","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"joi200119r6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"issue":"15","key":"joi200119r7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"joi200119r8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"issue":"1","key":"joi200119r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"joi200119r10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13054-020-03194-w","article-title":"International variation in the management of severe COVID-19 patients.","volume":"24","author":"Azoulay","year":"2020","journal-title":"Crit Care"},{"key":"joi200119r14","article-title":"Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19.","author":"Bhimraj","journal-title":"Clin Infect Dis"},{"issue":"25","key":"joi200119r15","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMe2015903","article-title":"The urgency of care during the COVID-19 pandemic: learning as we go.","volume":"382","author":"Rubin","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"joi200119r16","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1513\/AnnalsATS.202005-478SD","article-title":"Rationale and design of ORCHID: a randomized placebo-controlled clinical trial of hydroxychloroquine for adults hospitalized with COVID-19.","volume":"17","author":"Casey","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"24","key":"joi200119r17","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.1161\/CIRCULATIONAHA.120.047521","article-title":"Considerations for drug interactions on QTc in exploratory COVID-19 treatment.","volume":"141","author":"Roden","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"joi200119r18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19).","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"joi200119r20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol: a new facility for the measurement of health-related quality of life.","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"issue":"10","key":"joi200119r21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"7","key":"joi200119r22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1164\/rccm.201810-2050CP","article-title":"Reappraisal of ventilator-free days in critical care research.","volume":"200","author":"Yehya","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"joi200119r23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"21","key":"joi200119r24","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine: reporting of subgroup analyses in clinical trials.","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"},{"issue":"446","key":"joi200119r25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"7826","key":"joi200119r31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"issue":"7826","key":"joi200119r32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41586-020-2575-3","article-title":"Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.","volume":"585","author":"Hoffmann","year":"2020","journal-title":"Nature"},{"key":"joi200119r33","article-title":"Effect of hydroxychloroquine in hospitalized patients with COVID-19.","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"joi200119r34","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19.","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"joi200119r35","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial.","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"joi200119r36","first-page":"994","article-title":"Remdesivir for the treatment of COVID-19: preliminary report: reply.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"joi200119r37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109815","article-title":"Does zinc supplementation enhance the clinical efficacy of chloroquine\/hydroxychloroquine to win today\u2019s battle against COVID-19?","volume":"142","author":"Derwand","year":"2020","journal-title":"Med Hypotheses"},{"key":"joi200119r1","unstructured":"Johns Hopkins University. Coronavirus resource center. Accessed July 28, 2020. https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"joi200119r2","unstructured":"World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Accessed September 22, 2020. https:\/\/covid19.who.int\/"},{"key":"joi200119r11","unstructured":"Massachusetts General Hospital. Massachusetts General Hospital COVID-19 treatment guidance. Accessed May 8, 2020. https:\/\/web.archive.org\/web\/20200410013441\/https:\/\/www.massgeneral.org\/assets\/MGH\/pdf\/news\/coronavirus\/mass-general-COVID-19-treatment-guidance.pdf"},{"key":"joi200119r12","unstructured":"Vanderbilt University Medical Center. Clinical recommendations for treatment of COVID-19 adult patients. Accessed March 13, 2020. https:\/\/www.vumc.org\/coronavirus\/sites\/default\/files\/COVID%20Documents\/VUMC%20interim%20recommendations%20for%20clinical%20care%20of%20COVID%20patients%203.14.2020%20final.pdf"},{"key":"joi200119r13","unstructured":"National Institutes of Health (NIH). Coronavirus disease 2019 (COVID-19) treatment guidelines. Accessed June 30, 2020. https:\/\/www.covid19treatmentguidelines.nih.gov"},{"key":"joi200119r19","unstructured":"World Health Organization. WHO R&D blueprint: novel coronavirus: COVID-19 therapeutic trial synopsis. Accessed June 28, 2020. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf"},{"key":"joi200119r26","unstructured":"RECOVERY Investigators. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19: statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020. Accessed June 28, 2020. https:\/\/www.recoverytrial.net\/news\/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19"},{"key":"joi200119r27","unstructured":"Food and Drug Administration (FDA). Fact sheet for healthcare providers: emergency use authorization (EUA) of Veklury (remdesivir) for hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg. Accessed October 8, 2020. https:\/\/www.fda.gov\/media\/137566\/download"},{"key":"joi200119r28","unstructured":"Medicines and Healthcare Products Regulatory Agency. MHRA suspends recruitment to COVID-19 hydroxychloroquine trials. Accessed October 10, 2020. https:\/\/www.gov.uk\/government\/news\/mhra-suspends-recruitment-to-covid-19-hydroxychloroquine-trials"},{"key":"joi200119r29","unstructured":"Food and Drug Administration (FDA). Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. Accessed July 2, 2020. https:\/\/www.fda.gov\/media\/136534\/download"},{"key":"joi200119r30","unstructured":"Food and Drug Administration (FDA). Letter revoking EUA for chloroquine phosphate and hydroxychloroquine sulfate. Accessed July 2, 2020. https:\/\/www.fda.gov\/media\/138945\/download"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2772922\/jama_self_2020_oi_200119_1606767652.12648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T17:52:29Z","timestamp":1606845149000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2772922"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":37,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.22240","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}